TP53 and poorly differentiated thyroid gland carcinoma: When crossed with p53-flox or p53 knockout mice, the loss of p53 synergizes with the BRAFV600E creating a more aggressive PTC that progresses to poorly differentiated thyroid cancer (PDTC) and eventually ATCs (33, 34, 35).